Covihalt Current Affairs, GK & News

Lupin Ltd launched its version of Favipiravir under brand name Covihalt, in India

The Indian Pharmaceuticals major company, Lupin, has launched its version of the antiviral drug Favipiravir to treat the deadly COVI 19 disease. It has been informed by the company in an exchange filing. The drug has been launched with the brand name ‘Covihalt’ for the treatment of mild-to-moderate COVID 19 among the patients. The Drug ..